Danimer Scientific, Inc. (NYSE:DNMR) Q1 2024 Results Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants Blake Chamblee - Director of Financial Reporting Stephen Croskrey - Chairman and Chief Executive Officer Mike Hajost - Chief Financial Officer Conference Call Participants Jon Tanwanteng - CJS Securities Dan Rizzo - Jefferies LLC Operator Greetings. Welcome to the Danimer Scientific 2024 First Quarter Earnings Call. At this time all lines are in listen-only mode. Following the presentati ...

o UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Commission File Number: 001-39280 DANIMER SCIENTIFIC, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 84-1924518 ( State or other jurisdi ...

Danimer Scientific Announces First Quarter 2024 Results -- PHA Revenue Increase of 64% Year-Over-Year – -- First Commercial Order Received for 20-Million Pound Cutlery Award -- -- Previously Announced $20 Million Revolving Credit Facility Provides for Additional Liquidity – -- Previously Announced Proposed Pro-Rata Warrant Dividend Transaction -- BAINBRIDGE, GA – May 7, 2024 – Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the dev ...

The market expects Danimer Scientific, Inc. (DNMR) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report. On the other hand, i ...

Danimer Scientific, Inc. (DNMR) has been on a downward spiral lately with significant selling pressure. After declining 41.7% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in oversold territory and there is strong agreement among Wall Street analysts that the company will report better earnings than they predicted earlier.Guide to Identifying Oversold StocksWe use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whe ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39280 DANIMER SCIENTIFIC, INC. (Exact name of Registrant as specified in its Charter) Delaware 84-1924518 (State or other jurisdictio ...

Danimer Scientific, Inc. (NYSE:DNMR) Q4 2023 Earnings Conference Call March 28, 2024 4:30 PM ET Company Participants Blake Chamblee - Investor Relations Steve Croskrey - Chairman and Chief Executive Officer Mike Hajost - Chief Financial Officer Conference Call Participants Jon Tanwanteng - CJS Securities Thomas Boyes - TD Cowen Laurence Alexander - Jefferies Operator Welcome to the Danimer Scientific 2023 Fourth Quarter Earnings Call. At this time all lines are in listen-only mode. Following the presentatio ...

Danimer Scientific Announces Preliminary Fourth Quarter and Full Year 2023 Results -- PHA Revenue Up 11% Year-Over-Year in Fourth Quarter of 2023 -- -- Previously Announced Cutlery Award Poised to Expand -- -- PHA Revenue Increase of Approximately 60% Year-Over-Year Expected in First Quarter 2024 - -- Expects to Become Adjusted EBITDA Positive in Early 2025 -- -- Announces Date for Fourth Quarter and Full Year 2023 Earnings Call -- BAINBRIDGE, GA – March 20, 2024 – Danimer Scientific, Inc. (NYSE: DNMR) (“Da ...

BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced it has successfully completed the expansion of its Rochester, NY demonstration plant in order to better serve partners for the testing of Rinnovo® polymers. Rinnovo® is a type of polyhydroxyalkanoate (“PHA”) synthesized using a thermocatalytic process, which the Company believ ...

BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading, next-generation bioplastics company focused on the production of biodegradable materials, is pleased to announce that Dr. David Moody and Mr. Richard Altice have been appointed as members of Danimer’s Board of Directors. Dr. Moody’s appointment is effective immediately, and Mr. Altice’s appointment is effective as of April 15, 2024. Dr. David J. Moody currently is a member of the Board of Direct ...